封面
市场调查报告书
商品编码
1983227

酵素结合免疫吸附检测法(ELISA) 市场:依方法、应用、技术及地区划分

Enzyme Linked Immunosorbent Assay (ELISA) Market, By Method, By Application, By Technology, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2026 年,ELISA(酵素结合免疫吸附检测法)市场规模将达到 24.566 亿美元,到 2033 年将达到 34.76 亿美元。预计从 2026 年到 2033 年,其复合年增长率将达到 5.1%。

报告范围 报告详情
基准年: 2025 2026年市场规模: 24.566亿美元
历史数据时期: 2020年至2024年 预测期: 2026年至2033年
2026年至2033年预测期间的复合年增长率: 5.10% 2033年市场规模预测: 34.76亿美元

酵素连结免疫吸附试验(ELISA)是免疫检测。在生物医学领域,ELISA 被用作一种诊断工具,透过检测颜色变化来识别目标物质并测量其在测试样本中的浓度。 ELISA 的常见诊断应用包括 HIV 感染(人类免疫力缺乏病毒)、怀孕检测以及细胞激素和可溶性蛋白质的测定。此免疫检测利用各种抗原-抗体组合,包括酵素标记的抗原或抗体,来测量酵素活性。根据抗原-抗体组合的不同, 检测法可分为直接 ELISA、间接 ELISA、夹心 ELISA 和竞争性 ELISA。 HIV 等感染疾病的日益流行,以及人们对癌症和自体免疫疾病诊断意识的不断提高,是推动 ELISA 需求增长的主要因素,旨在透过早期、准确的疾病诊断来减轻慢性疾病的负担。

市场动态

预计在预测期内,市场新参与企业不断推出新产品将推动全球ELISA市场成长。例如,2020年6月17日,体外诊断(IVD)产业的全球性公司J Mitra & Co Pvt Ltd在印度市场推出了一款COVID-19总抗体检测ELISA检测套组。本检测套组能够检测所有COVID-19抗体,且不区分抗体类型,使其具有优异的性能。

本次调查的主要特点。

  • 本报告对全球 ELISA 市场进行了详细分析,以 2021 年为基准年,给出了预测期(2022-2030 年)的市场规模和复合年增长率。
  • 本报告指出了各个细分市场的潜在商机,并说明了该市场中具有吸引力的投资提案矩阵。
  • 此外,本研究还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
  • 本报告根据以下参数介绍了全球 ELISA 市场中的主要企业概况:公司概况、产品系列、主要亮点、财务表现和策略。
  • 透过利用本报告中提出的见解,企业行销负责人和经营团队将能够就未来的产品发布、产品升级、市场扩张和行销策略做出明智的决策。
  • 本报告面向该产业的各类相关人员,包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
  • 相关人员可以透过利用全球 ELISA 市场分析中使用的各种策略矩阵,更轻鬆地做出决策。

目录

第一章:研究目标与前提条件

  • 研究目标
  • 前提
  • 简称

第二章 市场范围

  • 报告摘要
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章:市场动态、监管与趋势分析

  • 市场动态
    • 促进因素
    • 阻碍因素
    • 市场机会
  • 主要亮点
  • 市场趋势
  • PEST分析
  • 政府和非政府组织倡议
  • 流行病学

第四章 全球 ELISA 市场:依方法划分,2026-2033 年

  • 概述
  • 直接ELISA
  • 间接ELISA
  • 夹心ELISA
  • 竞争性ELISA

第五章 全球 ELISA 市场:依应用领域划分,2026-2033 年

  • 概述
  • 疫苗研发
  • 免疫
  • 诊断
  • 毒性
  • 药物监测和製药业
  • 移植

第六章 全球 ELISA 市场:依技术划分,2026-2033 年

  • 化学冷光
  • 比色法
  • 萤光

第七章 全球 ELISA 市场:依地区划分,2026-2033 年

  • 北美洲
    • 我们
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 法国
    • 西班牙
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韩国
    • 亚太其他地区
  • 中东
    • GCC
    • 以色列
    • 其他中东国家
  • 非洲
    • 北非
    • 中非
    • 南非

第八章 竞争情势

  • 热图分析
  • 市占率分析
  • 公司简介
    • Bio-Rad Laboratories, Inc.
    • Enzo Life Sciences, Inc.
    • Thermo Fisher Scientific, Inc.
    • Biomerieux SA
    • Alpco
    • BioLegand, Inc.
    • R&D;Systems
    • Creative Diagnostics
    • Zeus Scientific, Inc.
    • Shenzhen YHLO Biotech Co., Ltd.

第九章

  • 调查方法
  • 关于本公司
简介目录
Product Code: CMI1505

Enzyme Linked Immunosorbent Assay Market is estimated to be valued at USD 2,456.60 Mn in 2026 and is expected to reach USD 3,476.00 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.1% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 2,456.60 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 5.10% 2033 Value Projection: USD 3,476.00 Mn

Enzyme Linked Immunosorbent Assay (ELISA) is an immunoassay used to identify proteins, peptides, antibodies, and hormones. ELISA assay has application in biotechnology medicine, as a diagnostic tool, which detects color change to identify a target substance and measures its concentration in the test sample. The common diagnostic applications of ELISA are (Human Immunodeficiency Virus) HIV infection, pregnancy tests, and measurement of cytokines, soluble proteins, and others. Various antigen-antibody combinations are used in the immunoassay that include an enzyme-labeled antigen or antibody and enzyme activity is measured. On the basis of antigen-antibody combination, the assay is segmented into direct ELISA, indirect ELISA, sandwich ELISA, and competitive ELISA. Increasing prevalence of infectious disease such as HIV and increasing awareness regarding diagnosis of cancer and autoimmune diseases are major factors propelling demand for ELISA to reduce the burden of chronic diseases with early and accurate disease diagnosis.

Market Dynamics

Increasing product launches by market players is expected to of drive growth of the global Enzyme Linked Immunosorbent Assay (ELISA) Market over the forecast period. For instance, On June 17, 2020, J Mitra & Co Pvt Ltd, a global company in the In-Vitro Diagnostics (IVD) industry had launched COVID-19 total antibody detection Elisa test kit in the Indian market. It is a Double-Sandwich Elisa technology, the test kit is known as COVID-19 [IgM, IgG, IgA] MICROLISA. It is a serology-based total antibody (IgM, IgG, IgA) detection assay. All the COVID-19 antibodies are detected without differentiation in antibodies, and this is the reason contributing to the superior performance of this test.

Key features of the study

  • This report provides an in-depth analysis of the global Enzyme Linked Immunosorbent Assay (ELISA) Market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global Enzyme Linked Immunosorbent Assay (ELISA) Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Thermo Fisher Scientific, Inc., Biomerieux S.A., Alpco, BioLegand, Inc., R&D Systems, Creative Diagnostics, Zeus Scientific, Inc., and Shenzhen YHLO Biotech Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global Enzyme Linked Immunosorbent Assay (ELISA) Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Enzyme Linked Immunosorbent Assay (ELISA) Market

Market Segmentation

  • By Method
    • Direct ELISA
    • Indirect ELISA
    • Sandwich ELISA
    • Competitive ELISA
  • By Application
    • Vaccine Development
    • Immunology
    • Diagnostics
    • Toxicology
    • Drug Monitoring & Pharmaceutical Industry
    • Transplantation
  • By Technology
    • Chemiluminescent
    • Colorimetric
    • Fluorescent
  • By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
  • Key Players
    • Bio-Rad Laboratories, Inc.
    • Enzo Life Sciences, Inc.
    • Thermo Fisher Scientific, Inc.
    • Biomerieux S.A.
    • Alpco, BioLegand, Inc.
    • R&D Systems
    • Creative Diagnostics
    • Zeus Scientific, Inc.
    • Shenzhen YHL.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Method
    • Market Snapshot, By Application
    • Market Snapshot, By Technology
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Key Highlights
  • Market Trends
  • PEST Analysis
  • Government & Non-Government Initiatives
  • Epidemiology

4. Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Method, 2026 - 2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Direct ELISA
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Indirect ELISA
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Sandwich ELISA
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Competitive ELISA
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Application, 2026 - 2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Vaccine Development
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Immunology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Diagnostics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Toxicology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Drug Monitoring & Pharmaceutical Industry
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Transplantation
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Technology, 2026 - 2033, (USD Mn)

    • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 20230
    • Segment Trends
  • Chemiluminescent
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Colorimetric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Fluorescent
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

7. Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Region, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2026-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Method, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Method, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Method, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • UK
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Method, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Method, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Method, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profiles
    • Bio-Rad Laboratories, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Enzo Life Sciences, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Thermo Fisher Scientific, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Biomerieux S.A.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Alpco
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • BioLegand, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • R&D Systems
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Creative Diagnostics
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Zeus Scientific, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Shenzhen YHLO Biotech Co., Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies

9. Section

  • Research Methodology
  • About Us